Paul Meyvisch
0000-0002-7248-4273
5 papers found
Refreshing results…
Shrinkage estimation for dose-response modeling in phase II trials with multiple schedules
On the relationship between association and surrogacy when both the surrogate and true endpoint are binary outcomes
Systematic review with meta-analysis: hepatitis B surface antigen decline and seroclearance in chronic hepatitis B patients on nucleos(t)ide analogues or pegylated interferon therapy
Assessing the predictive value of a binary surrogate for a binary true endpoint based on the minimum probability of a prediction error
Evaluation of six months sputum culture conversion as a surrogate endpoint in a multidrug resistant-tuberculosis trial
Missing publications? Search for publications with a matching author name.